كتاب
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
| العنوان: | Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group |
|---|---|
| المؤلفون: | Damaschin, C., Goergen, H., Kreissl, S., Plütschow, A., Breywisch, F., Mathas, S., Meissner, J., Sökler, M., Topp, M.S., Vucinic, V., Zimmermann, A., von Tresckow, B., Fuchs, M., Engert, A., Borchmann, P., Eichenauer, D.A. |
| بيانات النشر: | Nature Publishing Group |
| سنة النشر: | 2022 |
| المجموعة: | Max-Delbrueck-Center for Molecular Medicine, Berlin: MDC Repository |
| مصطلحات موضوعية: | Cancer Research, Topic 3: Integrative Biomedicine |
| نوع الوثيقة: | manuscript |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | http://edoc.mdc-berlin.de/20855/1/20855oa.pdfTest; Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Damaschin, C. and Goergen, H. and Kreissl, S. and Plütschow, A. and Breywisch, F. and Mathas, S. and Meissner, J. and Sökler, M. and Topp, M.S. and Vucinic, V. and Zimmermann, A. and von Tresckow, B. and Fuchs, M. and Engert, A. and Borchmann, P. and Eichenauer, D.A. Leukemia 36 (2): 580-582. February 2022 |
| DOI: | 10.1038/s41375-021-01386-z |
| الإتاحة: | https://doi.org/10.1038/s41375-021-01386-zTest http://edoc.mdc-berlin.de/20855Test/ https://edoc.mdc-berlin.de/20855Test/ http://edoc.mdc-berlin.de/20855/1/20855oa.pdfTest |
| حقوق: | cc_by_4 |
| رقم الانضمام: | edsbas.1DEFB274 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1038/s41375-021-01386-z |
|---|